Full-Scale Entry into the Pet Healthcare Business

GC Green Cross LabCell Establishes 'GreenVet,' a Specialized Pet Diagnostic Testing Company View original image


[Asia Economy Reporter Kim Ji-hee] GC Green Cross LabCell announced on the 4th that it has established an animal diagnostic testing specialized company, ‘Green Vet’, and is making a full-scale entry into the pet healthcare business.


Green Vet aims to realize total healthcare in the pet sector. It plans to provide preventive, treatment, and health management services that can manage the entire life cycle of pets, including diagnostic testing.


Detailed business strategies were also presented. In the diagnostic testing field, the company has strengthened expertise by forming a screening center staffed with veterinarians, including former Korean Clinical Veterinary Medicine Association director Park Su-won. In the fields of vaccines, diagnostic kits, pharmaceuticals, and special feed, the company plans to expand its business not only through direct development but also distribution via related investments and partnerships.


Green Vet is expected to rapidly penetrate the market. Since the capabilities and know-how of GC Green Cross LabCell’s core businesses?diagnostics and bio-logistics?form the foundation of this business, it is analyzed that this can be a stable driving force leading the company’s sustainable growth. In particular, the company expects to rank first in market share in the diagnostic testing field in 2022.



Park Dae-woo, CEO of GC Green Cross LabCell, said, “Green Vet’s competitiveness lies in aiming for total healthcare that accompanies the pet’s life, not care limited to a specific field,” adding, “We will not only present a new standard for the pet business but also strengthen research and development and business capabilities through steady investment and promote entry into the global market in the future.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing